Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Status:
Terminated
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of TAK-875, once daily
(QD), plus metformin compared to glimepiride plus metformin in participants with type 2
diabetes mellitus (T2DM).
The purpose of this study is to determine the efficacy and safety of TAK-875, once daily
(QD), plus metformin compared to glimepiride plus metformin in participants with type 2
diabetes mellitus (T2DM).